IFN signaling |
JAK2 STAT1/2 |
IFNAR-deficiency protects from liver injury |
I/R |
[99] |
IFN-α promotes liver injury |
I/R |
[100] |
IFNAR-deficiency delays experimental intoxication injury |
APAP |
[101] |
Transcription factors |
IRF-1 |
hepatocellular graft IRF-1 promotes experimental liver transplant injury |
I/R |
[102] |
promotes experimental liver injury by enhancing hepatocyte apoptosis |
I/R |
[100] |
promotes injury via IL-15 |
I/R |
[103] |
promotes injury via activation of PMNs |
I/R |
[104] |
activates autophagic cell death, aggravates hepatic injury |
I/R |
[105,106] |
mediates HMGB1 release |
I/R |
[105,106] |
IRF-2 |
IRF-1 antagonist, protective against liver injury |
I/R |
[107] |
IRF-3 |
linking alcohol-induced ER stress with hepatocyte apoptosis |
ALD |
[80] |
IRF-9 |
mediator of liver injury |
I/R |
[108] |
Sensitizing for DAMPs |
TLR4 |
involved in ROS-mediated HMGB1 release in liver injury |
I/R |
[48] |
engages disulfide-HMGB1 thereby promoting liver injury |
I/R |
[24] |
mediates KC type I IFN activation in experimental liver injury |
I/R |
[99] |
facilitates HMGB1-driven paracrine cytolytic effect on cholesterol-loaded hepatocytes |
NASH |
[78,79] |
senses NMI and IFP35 in experimental liver intoxication |
APAP |
[98] |
TLR9 |
senses mtDNA in experimental intoxication |
APAP |
[109] |
promotes experimental liver injury |
NASH |
[110] |
cGAS |
promotes exp. liver injury by sensing extracellular DNA |
APAP |
[101] |
deletion of cGAS aggravates experimental liver injury independent of STING |
I/R |
[111] |
STING |
promotes exp. liver injury by sensing extracellular DNA |
APAP |
[101] |
promotes IRF-3-mediated parenchymal apoptotic cell death in response to alcohol |
ALD |
[80] |
Acting as DAMPs |
NMI |
released by activated macrophages acting on TLR4 in experimental intoxication |
APAP |
[98] |
NMI deficiency reduces liver injury and mortality |
APAP |
[98] |
IFP35 |
released by activated macrophages acting on TLR4 in experimental intoxication |
APAP |
[98] |